Home> Products> fxr activation

{ "products": [ { "_id": "69142bf71d499513a92e5772", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Nicorandil Tablets 5mg", "description": "Nicorandil Tablets 5 mg is a vasodilatory anti-anginal medication widely prescribed for the management and prevention of angina pectoris (chest pain) associated with coronary artery disease (CAD). Angina results from an imbalance between the heart’s oxygen demand and supply due to restricted blood flow in the coronary arteries. Nicorandil offers a dual mechanism of action — acting both as a nitrate-like vasodilator and a potassium channel opener, making it unique among anti-anginal agents.\n\nBy improving oxygen delivery to the myocardium and reducing cardiac workload, Nicorandil 5 mg Tablets provide effective relief from anginal pain and reduce the frequency and severity of ischemic episodes. It is also beneficial in preventing future attacks, improving exercise tolerance, and enhancing the overall quality of life in patients with chronic stable angina.\n\nComposition\n\nEach tablet contains:\n\nNicorandil IP – 5 mg\n\nExcipients – q.s.\n\nNicorandil tablets are available in film-coated form to ensure stability, easy swallowing, and optimal absorption. They are manufactured in compliance with Good Manufacturing Practices (GMP) standards to ensure safety, purity, and efficacy.\n\nPharmacological Action / Mechanism of Action\n\nNicorandil exhibits a dual mechanism that makes it distinct among anti-anginal drugs:\n\nNitrate-Like Effect:\nNicorandil acts as a nitric oxide (NO) donor. Nitric oxide activates guanylate cyclase, increasing cyclic GMP (cGMP) levels in vascular smooth muscle. This leads to relaxation of blood vessels, particularly veins and large arteries, thereby reducing preload and afterload on the heart. This nitrate-like activity lowers myocardial oxygen demand.\n\nPotassium Channel Opening Effect:\nNicorandil opens ATP-sensitive potassium (KATP) channels in vascular smooth muscle, resulting in arteriolar vasodilation. This increases coronary blood flow and improves oxygen supply to ischemic heart tissues.\n\nTogether, these effects reduce cardiac workload, enhance coronary perfusion, and prevent anginal pain by correcting the oxygen supply-demand mismatch in the heart muscle.\n\nUses and Indications\n\nNicorandil Tablets 5 mg are indicated for the treatment and prevention of angina pectoris in adults, particularly:\n\nChronic Stable Angina:\n\nHelps reduce the frequency and severity of chest pain associated with exertion or emotional stress.\n\nProphylaxis of Angina Attacks:\n\nUsed regularly to prevent anginal episodes, especially in patients with known coronary artery disease.\n\nAdjunct Therapy in Ischemic Heart Disease (IHD):\n\nCan be used alongside beta-blockers, calcium channel blockers, or antiplatelet drugs for enhanced symptom control and long-term protection.\n\nImprovement of Exercise Tolerance:\n\nReduces the likelihood of anginal pain during physical activity, enabling patients to perform daily tasks comfortably.\n\nIn some clinical cases, Nicorandil is also considered for post-myocardial infarction recovery, as it improves coronary perfusion, although this is at the discretion of a cardiologist.\n\nDosage and Administration\n\nRecommended Starting Dose: 5 mg to 10 mg twice daily.\n\nMaintenance Dose: May be increased gradually to 10–20 mg twice daily, depending on clinical response and tolerance.\n\nThe tablets should be swallowed whole with water, preferably at the same times each day.\n\nNicorandil should not be stopped abruptly; dosage tapering is recommended to avoid rebound angina.\n\nAlways follow the dosage instructions provided by the physician.\n\nKey Benefits\n\nDual Mechanism for Comprehensive Relief:\nCombines nitrate-like and potassium channel-opening properties for both arterial and venous dilation, providing superior protection against anginal attacks.\n\nImproves Coronary Blood Flow:\nDilates coronary arteries, increasing oxygen delivery to ischemic myocardial tissues.\n\nReduces Cardiac Workload:\nBy decreasing preload (venous return) and afterload (arterial resistance), Nicorandil minimizes the heart’s oxygen consumption.\n\nRapid Onset of Action:\nNicorandil acts within a short duration, offering quick relief from anginal discomfort.\n\nPrevents Future Angina Episodes:\nRegular use helps maintain steady control of chest pain, improving exercise capacity and quality of life.\n\nCompatible with Other Cardiac Medications:\nCan be safely used alongside antiplatelet agents, beta-blockers, ACE inhibitors, and statins as part of comprehensive cardiac care.\n\nFavorable Safety Profile:\nCompared to nitrates, Nicorandil carries a lower risk of tolerance development, making it suitable for long-term therapy.\n\nEnhances Myocardial Protection:\nNicorandil’s KATP channel activation provides additional cardioprotective effects by improving microvascular blood flow and limiting ischemic damage during stress.\n\nPrecautions and Warnings\n\nAlthough Nicorandil is generally well-tolerated, certain precautions are advised:\n\nHypotension:\nNicorandil may cause a drop in blood pressure due to vasodilation. Caution is advised in patients with hypotension or dehydration.\n\nConcurrent Use with Nitrates:\nShould not be used together with other nitrate medications to avoid severe hypotension.\n\nOral or Gastrointestinal Ulcers:\nRarely, Nicorandil may cause ulcerations in the mouth, intestines, or skin. Treatment should be discontinued if ulceration occurs.\n\nPatients with Low Blood Volume:\nUse cautiously in individuals with hypovolemia or those on diuretics.\n\nDriving and Machinery:\nDizziness or light-headedness may occur; avoid driving until effects are known.\n\nPregnancy and Lactation:\nShould be used only if prescribed by a physician when the potential benefits outweigh the risks.\n\nPossible Side Effects\n\nNicorandil is generally safe but may cause some side effects, particularly at the start of therapy or with higher doses. Common and rare adverse reactions include:\n\nCommon Side Effects:\n\nHeadache (due to vasodilation)\n\nFlushing or warmth sensation\n\nDizziness or light-headedness\n\nNausea or mild stomach upset\n\nFatigue or weakness\n\nLess Common / Rare Side Effects:\n\nHypotension (low blood pressure)\n\nPalpitations or tachycardia\n\nMouth ulcers, anal ulcers, or skin ulceration (uncommon but serious — discontinue if occurs)\n\nRash or allergic reaction\n\nVisual disturbances (rare and usually reversible)\n\nIf any severe reaction or persistent discomfort occurs, medical attention should be sought promptly.\n\nDrug Interactions\n\nAvoid concomitant use with nitrates or phosphodiesterase type-5 inhibitors (e.g., Sildenafil, Tadalafil), as it may cause a dangerous fall in blood pressure.\n\nCaution with antihypertensive drugs or diuretics, which may enhance hypotensive effects.\n\nAlcohol consumption can potentiate dizziness or hypotension and should be limited.\n\nStorage and Handling\n\nStore below 30°C, protected from moisture and direct sunlight.\n\nKeep out of reach of children.\n\nDo not use tablets past the expiry date or if the packaging is damaged.\n\nConclusion\n\nNicorandil Tablets 5 mg offer a modern and effective approach to managing angina pectoris, providing reliable relief through their dual-action mechanism. By combining nitrate-like vasodilation with potassium channel opening, Nicorandil ensures both oxygen supply improvement and reduction of cardiac workload — the cornerstone of angina management.\n\nIt is well-tolerated, fast-acting, and suitable for long-term therapy, making it a preferred choice for patients with chronic stable angina. Regular use under medical supervision helps reduce the frequency of chest pain, improve physical endurance, and enhance the overall quality of life in individuals with coronary artery disease.", "price": 381.0, "discountamount": 115.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2202, "imageuri": "https://productimages.withfloats.com/actual/69142c03b53db80943abd33d.png", "tileimageuri": "https://productimages.withfloats.com/tile/69142c03b53db80943abd33d.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-12T06:40:55.795Z", "updatedon": "2025-12-09T05:59:32.564Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/nicorandil-tablets-5mg/2202", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MAYORANDIL 5 ", "category": "CARDIOLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666a92dd1542dd108c561935", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LACOSMILE 50 ", "description": "LACOSMILE 50 \nLacosamide (50mg)\nIntroduction:\n\nLACOSMILE 50 contains Lacosamide (50 mg), a medication used to treat partial-onset seizures in patients with epilepsy. Lacosamide helps stabilize electrical activity in the brain, reducing the frequency and severity of seizures and improving the overall quality of life for individuals with epilepsy.\nKey Features and Benefits:\n\nSeizure Control: Lacosamide is effective in controlling partial-onset seizures, helping patients achieve better management of their condition.\nNeurostabilization: It works by selectively enhancing the slow inactivation of voltage-gated sodium channels, which stabilizes hyperexcitable neuronal membranes and prevents seizure activity.\nAdjunctive Therapy: Lacosamide can be used as an adjunctive therapy in combination with other antiepileptic drugs (AEDs), providing additional seizure control for patients who do not achieve full control with a single medication.\nImproved Quality of Life: By reducing the occurrence of seizures, Lacosamide helps improve the overall quality of life for individuals with epilepsy, allowing them to engage more fully in daily activities and reducing the impact of the disorder on their lives.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of LACOSMILE 50 (Lacosamide 50 mg) is 50 mg taken twice daily. The dosage may be gradually increased based on the patient's response to treatment and tolerability.\nMaintenance Dosage: The usual maintenance dose is 200 mg to 400 mg per day, divided into two doses. The exact dosage should be determined by a healthcare provider.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Lacosamide at the same times each day to maintain consistent medication levels in the bloodstream.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/lacosmile-50-133576", "price": 75.0, "discountamount": 22.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "life", "AEDs", "food", "brain", "EMAIL", "lives", "water", "impact", "tablet", "epilepsy", "response", "disorder", "patients", "severity", "Benefits", "frequency", "LACOSMILE", "two doses", "treatment", "condition", "management", "same times", "occurrence", "combination", "information", "individuals", "bloodstream", "sterispharma", "tolerability", "sterisonline", "Introduction", "full control", "exact dosage", "Key Features", "CALL/WHATSAPP", "Administration", "Initial Dosage", "overall quality", "Improved Quality", "200 mg to 400 mg", "seizure activity", "daily activities", "Lacosamide 50 mg", "single medication", "slow inactivation", "Maintenance Dosage", "Neurostabilization", "Adjunctive Therapy", "healthcare provider", "electrical activity", "typical starting dose", "partial-onset seizures", "usual maintenance dose", "other antiepileptic drugs", "additional seizure control", "consistent medication levels", "voltage-gated sodium channels", "hyperexcitable neuronal membranes" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1840, "imageuri": "https://productimages.withfloats.com/actual/666a92e0475de163fe8f70bf.png", "tileimageuri": "https://productimages.withfloats.com/tile/666a92e0475de163fe8f70bf.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T06:34:05.541Z", "updatedon": "2024-06-26T10:45:15.427Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/lacosmile-50-/1840", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LACOSMILE 50 ", "category": "NEUROLOGYRANGE", "tags": [ "lacosamide 50 mg uses", "Lacosamide (50mg)", "", "lacosamide 50 mg price", "lacosamide 50 mg side effects", "lacosam 50 substitute" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666a91237e4bb91e30920b88", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LACOSMILE 200 ", "description": "LACOSMILE 200 \nLacosamide 200 mg\nIntroduction:\n\nLACOSMILE 200 contains Lacosamide (200 mg), an antiepileptic medication used to treat partial-onset seizures in patients with epilepsy. Lacosamide helps stabilize electrical activity in the brain, reducing the frequency and severity of seizures and improving the overall quality of life for individuals with epilepsy.\nKey Features and Benefits:\n\nSeizure Control: Lacosamide is effective in controlling partial-onset seizures, helping patients achieve better management of their condition.\nNeurostabilization: It works by selectively enhancing the slow inactivation of voltage-gated sodium channels, which stabilizes hyperexcitable neuronal membranes and prevents seizure activity.\nAdjunctive Therapy: Lacosamide can be used as an adjunctive therapy in combination with other antiepileptic drugs (AEDs), providing additional seizure control for patients who do not achieve full control with a single medication.\nImproved Quality of Life: By reducing the occurrence of seizures, Lacosamide helps improve the overall quality of life for individuals with epilepsy, allowing them to engage more fully in daily activities and reducing the impact of the disorder on their lives.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of LACOSMILE 200 (Lacosamide 200 mg) is 50 mg to 100 mg taken twice daily. The dosage may be gradually increased based on the patient's response to treatment and tolerability.\nMaintenance Dosage: The usual maintenance dose is 200 mg to 400 mg per day, divided into two doses. The exact dosage should be determined by a healthcare provider.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Lacosamide at the same times each day to maintain consistent medication levels in the bloodstream.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/lacosmile-200-134206", "price": 221.0, "discountamount": 66.3, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "AEDs", "food", "life", "brain", "EMAIL", "50 mg", "water", "lives", "100 mg", "tablet", "impact", "severity", "Benefits", "patients", "epilepsy", "disorder", "response", "LACOSMILE", "frequency", "treatment", "condition", "two doses", "management", "same times", "occurrence", "individuals", "bloodstream", "information", "combination", "tolerability", "sterispharma", "Introduction", "sterisonline", "exact dosage", "full control", "Key Features", "CALL/WHATSAPP", "Initial Dosage", "Administration", "overall quality", "200 mg to 400 mg", "seizure activity", "daily activities", "Improved Quality", "Lacosamide 200 mg", "single medication", "slow inactivation", "Maintenance Dosage", "Adjunctive Therapy", "Neurostabilization", "healthcare provider", "electrical activity", "typical starting dose", "partial-onset seizures", "usual maintenance dose", "antiepileptic medication", "other antiepileptic drugs", "additional seizure control", "consistent medication levels", "voltage-gated sodium channels", "hyperexcitable neuronal membranes" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1839, "imageuri": "https://productimages.withfloats.com/actual/666a91265d07e42fce8627c5.png", "tileimageuri": "https://productimages.withfloats.com/tile/666a91265d07e42fce8627c5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T06:26:43.662Z", "updatedon": "2024-06-26T10:44:03.607Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/lacosmile-200-/1839", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LACOSMILE 200 ", "category": "NEUROLOGYRANGE", "tags": [ "lacosamide 200 mg uses", "Lacosamide 200 mg", "", "lacosamide side effects", "lacosamide dose" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666a8fe21542dd108c561889", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LACOSMILE 150 ", "description": "LACOSMILE 150 \nLacosamide 150 mg\nIntroduction:\n\nLACOSMILE 150 contains Lacosamide (150 mg), an antiepileptic medication used to treat partial-onset seizures in patients with epilepsy. Lacosamide helps stabilize electrical activity in the brain, reducing the frequency and severity of seizures and improving the overall quality of life for individuals with epilepsy.\nKey Features and Benefits:\n\nSeizure Control: Lacosamide is effective in controlling partial-onset seizures, helping patients achieve better management of their condition.\nNeurostabilization: It works by selectively enhancing the slow inactivation of voltage-gated sodium channels, which stabilizes hyperexcitable neuronal membranes and prevents seizure activity.\nAdjunctive Therapy: Lacosamide can be used as an adjunctive therapy in combination with other antiepileptic drugs (AEDs), providing additional seizure control for patients who do not achieve full control with a single medication.\nImproved Quality of Life: By reducing the occurrence of seizures, Lacosamide helps improve the overall quality of life for individuals with epilepsy, allowing them to engage more fully in daily activities and reducing the impact of the disorder on their lives.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of LACOSMILE 150 (Lacosamide 150 mg) is 50 mg to 100 mg taken twice daily. The dosage may be gradually increased based on the patient's response to treatment and tolerability.\nMaintenance Dosage: The usual maintenance dose is 200 mg to 400 mg per day, divided into two doses. The exact dosage should be determined by a healthcare provider.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Lacosamide at the same times each day to maintain consistent medication levels in the bloodstream.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/lacosmile-150-134207", "price": 195.0, "discountamount": 58.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "AEDs", "life", "food", "lives", "water", "brain", "EMAIL", "tablet", "impact", "100 mg", "150 mg", "patients", "response", "disorder", "epilepsy", "severity", "Benefits", "frequency", "LACOSMILE", "two doses", "condition", "treatment", "management", "same times", "occurrence", "Lacosamide", "individuals", "combination", "information", "bloodstream", "sterispharma", "tolerability", "Introduction", "sterisonline", "Key Features", "exact dosage", "full control", "CALL/WHATSAPP", "Administration", "Initial Dosage", "overall quality", "Improved Quality", "200 mg to 400 mg", "seizure activity", "daily activities", "slow inactivation", "single medication", "Neurostabilization", "Adjunctive Therapy", "Maintenance Dosage", "electrical activity", "healthcare provider", "typical starting dose", "usual maintenance dose", "partial-onset seizures", "antiepileptic medication", "other antiepileptic drugs", "additional seizure control", "consistent medication levels", "voltage-gated sodium channels", "hyperexcitable neuronal membranes" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1838, "imageuri": "https://productimages.withfloats.com/actual/666a8fe5117f82c50b0ab68e.png", "tileimageuri": "https://productimages.withfloats.com/tile/666a8fe5117f82c50b0ab68e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T06:21:22.539Z", "updatedon": "2024-06-26T10:43:07.716Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/lacosmile-150-/1838", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LACOSMILE 150 ", "category": "NEUROLOGYRANGE", "tags": [ "lacosmile 150 mg side effects", "lacosamide mechanism of action", "Lacosamide 150 mg", "", "lacosamide 150 mg price", "lacosam 150 uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6669990670774b1f84f68318", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LACOSMILE 100 ", "description": "LACOSMILE 100 \nLacosamide (100mg)\nIntroduction:\n\nLACOSMILE 100 contains Lacosamide (100mg), an antiepileptic medication used to treat partial-onset seizures in patients with epilepsy. Lacosamide is known for its efficacy in controlling seizures and improving the quality of life for individuals with epilepsy by stabilizing electrical activity in the brain.\nKey Features and Benefits:\n\nSeizure Control: Lacosamide is effective in reducing the frequency and severity of partial-onset seizures, helping patients maintain better control over their condition.\nNeurostabilization: It works by selectively enhancing the slow inactivation of voltage-gated sodium channels, which helps stabilize hyperexcitable neuronal membranes and prevent seizure activity.\nAdjunctive Therapy: Lacosamide can be used as an adjunctive therapy in combination with other antiepileptic drugs (AEDs), providing additional seizure control for patients who do not achieve full control with a single medication.\nImproved Quality of Life: By reducing the occurrence of seizures, Lacosamide helps improve the overall quality of life for individuals with epilepsy, allowing them to engage more fully in daily activities and reducing the impact of the disorder on their lives.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of LACOSMILE 100 (Lacosamide 100mg) is 50mg to 100mg taken twice daily. The dosage may be gradually increased based on the patient's response to treatment and tolerability.\nMaintenance Dosage: The usual maintenance dose is 200mg to 400mg per day, divided into two doses.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Lacosamide at the same times each day to maintain consistent medication levels in the bloodstream.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/lacosmile-100-133575", "price": 121.9, "discountamount": 36.57, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "life", "50mg", "food", "AEDs", "brain", "water", "EMAIL", "400mg", "200mg", "100mg", "lives", "tablet", "impact", "disorder", "patients", "epilepsy", "response", "efficacy", "Benefits", "severity", "condition", "LACOSMILE", "two doses", "frequency", "treatment", "Lacosamide", "same times", "occurrence", "combination", "bloodstream", "information", "individuals", "tolerability", "sterispharma", "sterisonline", "Key Features", "Introduction", "full control", "CALL/WHATSAPP", "Initial Dosage", "Administration", "overall quality", "seizure activity", "Improved Quality", "daily activities", "single medication", "slow inactivation", "Neurostabilization", "Maintenance Dosage", "Adjunctive Therapy", "electrical activity", "typical starting dose", "partial-onset seizures", "usual maintenance dose", "antiepileptic medication", "other antiepileptic drugs", "additional seizure control", "consistent medication levels", "voltage-gated sodium channels", "hyperexcitable neuronal membranes" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1837, "imageuri": "https://productimages.withfloats.com/actual/66699907475de163fe8eda8d.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/66699907475de163fe8eda8d.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-12T12:48:06.109Z", "updatedon": "2024-06-26T10:42:01.426Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/lacosmile-100-/1837", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LACOSMILE 100 ", "category": "NEUROLOGY RANGE", "tags": [ "lacosamide 100 mg uses", "lacosamide का उपयोग", "Lacosamide Injection Uses in Hindi", "lacosamide mechanism of action", "lacosamide 100 mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "66698007162db023604894db", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "DONEPAZE M ", "description": "DONEPAZE M \nDonepazil 5mg + Mentatime 5mg\nIntroduction\nDONEPAZE M combines Donepezil (5 mg) and Memantine (5 mg) to offer a comprehensive treatment for Alzheimer's disease and cognitive enhancement. This combination medication works by targeting multiple pathways involved in the cognitive decline associated with Alzheimer's, providing a more robust solution for managing the symptoms of the disease and improving overall brain function.\n\nKey Ingredients and Their Benefits\nDonepezil (5 mg)\nCognitive Enhancement: Donepezil is a cholinesterase inhibitor that increases the levels of acetylcholine, a neurotransmitter essential for memory and learning, in the brain.\nMemory Improvement: By slowing the breakdown of acetylcholine, Donepezil helps enhance memory and learning capabilities in patients with Alzheimer's disease.\nSymptom Management: It effectively manages the symptoms of mild to moderate Alzheimer's disease, helping patients maintain their daily functions and quality of life.\nSlow Progression: Donepezil can slow the progression of Alzheimer's symptoms, providing significant benefits to patients and caregivers.\nMemantine (5 mg)\nNMDA Receptor Antagonist: Memantine works by blocking NMDA receptors, which are involved in the overactivation that can lead to neuronal damage in Alzheimer's disease.\nNeuroprotection: By regulating the activity of glutamate, Memantine helps protect neurons from excitotoxicity and supports brain health.\nCognitive Improvement: Memantine helps improve cognitive function, including memory, attention, and problem-solving skills in patients with moderate to severe Alzheimer's disease.\nBehavioral Symptom Management: It can also help manage behavioral symptoms associated with Alzheimer's, such as agitation and aggression.\nBenefits of DONEPAZE M\nDual Mechanism of Action: DONEPAZE M combines the benefits of Donepezil and Memantine, targeting multiple pathways involved in Alzheimer's disease for more comprehensive symptom management.\nEnhanced Cognitive Function: The combination improves cognitive abilities, including memory, attention, and problem-solving skills, in patients with Alzheimer's disease.\nSymptom Relief: It effectively manages both cognitive and behavioral symptoms of Alzheimer's, helping patients maintain their independence and perform daily activities.\nNeuroprotection: DONEPAZE M provides neuroprotective benefits by regulating neurotransmitter activity and protecting neurons from damage.\nOnce-Daily Dosing: The convenience of once-daily dosing improves patient compliance and ensures consistent therapeutic effects.\nDosage and Administration\nDosage\nAlzheimer’s Disease: The recommended starting dose is one tablet (Donepezil 5 mg + Memantine 5 mg) taken once daily. The dosage may be adjusted by the healthcare provider based on the patient's response and tolerance.\nAdministration\nOral Use: Swallow the tablet whole with a full glass of water. It can be taken with or without food.\nConsistency: For optimal results, take DONEPAZE M at the same time each day to maintain consistent medication levels in your bloodstream.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/donepaze-m-133559", "price": 167.0, "discountamount": 50.1, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mild", "life", "food", "EMAIL", "Order", "water", "Action", "Dosing", "quality", "disease", "neurons", "Oral Use", "response", "patients", "attention", "agitation", "same time", "tolerance", "glutamate", "Donepazil", "Mentatime", "Memantine", "breakdown", "aggression", "one tablet", "full glass", "caregivers", "DONEPAZE M", "bloodstream", "Consistency", "moderate to", "convenience", "information", "Introduction", "sterispharma", "sterisonline", "independence", "brain health", "acetylcholine", "starting dose", "CALL/WHATSAPP", "NMDA receptors", "excitotoxicity", "Dual Mechanism", "Symptom Relief", "Donepezil 5 mg", "overactivation", "Donepezil (5 mg", "Neuroprotection", "robust solution", "Key Ingredients", "daily functions", "optimal results", "neuronal damage", "severe Alzheimer", "Slow Progression", "daily activities", "cognitive decline", "multiple pathways", "moderate Alzheimer", "Memory Improvement", "patient compliance", "cognitive abilities", "behavioral symptoms", "healthcare provider", "significant benefits", "cognitive enhancement", "learning capabilities", "Administration Dosage", "Cognitive Improvement", "combination medication", "overall brain function", "problem-solving skills", "comprehensive treatment", "NMDA Receptor Antagonist", "neuroprotective benefits", "cholinesterase inhibitor", "neurotransmitter activity", "Enhanced Cognitive Function", "consistent medication levels", "Behavioral Symptom Management", "consistent therapeutic effects", "comprehensive symptom management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1823, "imageuri": "https://productimages.withfloats.com/actual/666980260b4fc76a99a080d2.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666980260b4fc76a99a080d2.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-12T11:01:27.347Z", "updatedon": "2024-06-27T05:51:11.327Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/donepaze-m-/1823", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "DONEPAZE M ", "category": "NEUROLOGY RANGE", "tags": [ "Mentatime 5mg", "Donepazil 5mg", "donepaze m tablet uses in hindi", "donepaze m tablet uses in telugu", "DONEPAZE M tablets price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6661a73687f0960e14a2c739", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "mycophenolate sodium 360 mg", "description": "MYCOPLASM S 360 \nMycophenolate sodium 360 mg is an essential immunosuppressant medication designed to prevent organ transplant rejection, particularly for kidney, heart, and liver transplants. As the sodium salt of mycophenolic acid, it delivers 360 mg of the active moiety per tablet, providing targeted immune suppression to help patients maintain their new organs long-term. This product stands out for its enteric-coated formulation, which enhances gastrointestinal tolerability compared to other forms, making it a preferred choice in post-transplant care regimens.​\n\nUses of Mycophenolate Sodium 360 mg\nMycophenolate sodium 360 mg primarily serves as a prophylactic agent against acute rejection in adult and pediatric patients receiving allogeneic renal, cardiac, or hepatic transplants. It works alongside other immunosuppressants like cyclosporine and corticosteroids to create a balanced regimen that minimizes the risk of graft loss. Clinically, it proves effective in de novo transplant recipients, where starting therapy early post-surgery significantly reduces rejection episodes. Beyond transplants, off-label applications include managing refractory autoimmune conditions such as lupus nephritis or myasthenia gravis, where immune overactivity damages tissues.​\n\nThe drug targets the proliferation of T- and B-lymphocytes, key players in immune responses that can attack transplanted organs. In renal transplant patients, for instance, it helps preserve kidney function by curbing antibody-mediated rejection. Its role extends to maintenance therapy, where consistent dosing sustains immunosuppression without excessive toxicity. Healthcare providers often adjust it based on patient response and trough levels of the active metabolite, mycophenolic acid (MPA), ensuring optimal therapeutic outcomes.​\n\nKey Benefits of Mycophenolate Sodium 360 mg\nMycophenolate sodium 360 mg offers several advantages that make it a cornerstone in transplant medicine. One primary benefit is its selective inhibition of lymphocyte proliferation, sparing other cell types and reducing broad-spectrum immunosuppression risks. This leads to fewer opportunistic infections compared to older agents like azathioprine. The enteric coating minimizes upper GI upset, improving patient compliance—studies show higher adherence rates with this formulation.​\n\nEnhanced Graft Survival: Prolongs organ viability by effectively suppressing cell-mediated and humoral immunity, with clinical data showing reduced biopsy-proven rejection rates.\n\nImproved Tolerability: Lower incidence of nausea and diarrhea due to delayed-release technology, allowing twice-daily dosing without food restrictions.\n\nFlexible Dosing: Equivalent to 720 mg mycophenolate mofetil, but with predictable MPA exposure via enterohepatic recirculation for steady-state efficacy.\n\nPediatric Suitability: Approved for children over 2 years in renal transplants, supporting growth without compromising safety.\n\nCost-Effective Long-Term Option: Balances efficacy and side effect profile, potentially lowering overall healthcare costs from fewer rejections or hospitalizations.​\n\nPatients experience better quality of life, with sustained energy levels and fewer interruptions from acute rejection crises. Its metabolism to MPA via liver glucuronidation ensures reliable pharmacokinetics, even in patients with mild renal impairment.​\n\nSide Effects of Mycophenolate Sodium 360 mg\nWhile highly effective, mycophenolate sodium 360 mg carries risks typical of immunosuppressants, necessitating vigilant monitoring. Common adverse effects stem from its impact on rapidly dividing cells, particularly in the gut and bone marrow.\n\nCommon Side Effects\nGastrointestinal issues like diarrhea, nausea, vomiting, and abdominal pain, affecting up to 30-50% of users.\n\nHeadache, insomnia, and tremor, often mild and transient.\n\nInfections such as urinary tract or respiratory, due to moderated immunity.\n\nHypertension or peripheral edema, manageable with supportive care.\n\nLeukopenia or anemia, requiring periodic blood counts.​\n\nSerious Side Effects\nSevere myelosuppression leading to neutropenia or thrombocytopenia, which can increase infection or bleeding risks.\n\nProgressive multifocal leukoencephalopathy (PML), a rare brain infection linked to JC virus reactivation.\n\nGastrointestinal perforation or bleeding, especially in at-risk patients.\n\nIncreased malignancy risk, including lymphoma or skin cancers, over long-term use.\n\nHypersensitivity reactions like rash or anaphylaxis.​\n\nRegular complete blood counts, viral monitoring (e.g., CMV, BK virus), and skin exams mitigate these risks. Dose reductions or discontinuation may be needed if counts drop significantly.​\n\nMechanism of Action\nMycophenolate sodium 360 mg rapidly hydrolyzes to mycophenolic acid (MPA), a potent, reversible, non-competitive inhibitor of inosine-5'-monophosphate dehydrogenase (IMPDH). This enzyme catalyzes the rate-limiting step in de novo guanine nucleotide synthesis, depleting guanosine nucleotides essential for T- and B-cell DNA replication. Lymphocytes, reliant on this pathway, undergo proliferation arrest, suppressing both cell-mediated immunity and antibody production.​\n\nMPA also hinders glycosylation of adhesion molecules on lymphocytes and monocytes, impeding their migration to graft sites. It reduces nitric oxide production in macrophages without affecting endothelial cells, curbing inflammation. Enterohepatic recirculation of the glucuronide metabolite (MPAG) prolongs MPA exposure, enhancing efficacy. Protein binding to albumin (around 97%) ensures targeted delivery, with clearance primarily renal for the inactive form.​\n\nDosage and Administration Guidelines\nStandard dosing for renal transplant is 720 mg (two 360 mg tablets) twice daily, starting within 72 hours post-surgery. Adjustments occur for hepatic or cardiac transplants, often alongside cyclosporine. Therapeutic drug monitoring of MPA AUC (area under curve) optimizes levels between 30-60 mcg·h/mL. Take on an empty stomach for best absorption, though food has minimal impact due to the coating.​\n\nPrecautions and Warnings\nAvoid in pregnancy (Category D) due to teratogenicity—use contraception and regular pregnancy tests. Contraindicated in active untreated infections. Monitor for GI bleeding in ulcerative colitis patients. Drug interactions with antacids, cholestyramine, or rifampin alter MPA levels. Live vaccines are prohibited.​\n\nConclusion\nMycophenolate sodium 360 mg represents a vital advancement in transplant immunosuppression, offering robust protection against rejection with a favorable benefit-risk profile. Its targeted action on lymphocytes, combined with improved GI tolerance, empowers patients to thrive post-transplant. By integrating it into comprehensive regimens with close monitoring, healthcare teams maximize graft success and patient well-being. Always consult a specialist for personalized guidance to harness its full potential safely.\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/mycoplasm-s-360-133670\n\n\n\n\n\n\n", "price": 767.0, "discountamount": 567.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "dose", "risk", "body", "part", "ORDER", "360mg", "Email", "cells", "dosage", "nausea", "vomiting", "schedule", "headache", "strength", "WhatsApp", "diarrhea", "activity", "rejection", "treatment", "infections", "supplements", "information", "MYCOPLASM S", "sterispharma", "sterisonline", "stomach pain", "blood counts", "immune system", "complications", "liver problems", "liver function", "other medications", "Regular monitoring", "medical conditions", "healthcare provider", "Common side effects", "Serious side effects", "white blood cell count", "potential drug interactions", "optimal therapeutic effects", "combination therapy regimen", "organ transplant recipients", "Mycophenolate Sodium therapy", "other immunosuppressive drugs" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1474, "imageuri": "https://productimages.withfloats.com/actual/6661a739c749b7962dbc08c6.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6661a739c749b7962dbc08c6.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:10:30.488Z", "updatedon": "2025-12-04T07:44:09.122Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/mycophenolate-sodium-360-mg/1474", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MYCOPLASM S 360 ", "category": "Oncology", "tags": [ "MYCOPLASM S 360", "Mycophenolate sodium (360mg)", "Mycophenolate sodium 360 mg price", "Mycophenolate sodium 360 mg brands", "Mycophenolate sodium 360 mg side effects", "Myfortic 360 alternative", "Myfortic 500" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6661a57d8da3a81d5c6a17dd", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Mycophenolate mofetil 500mg", "description": "MYCOPLASM M 500\nMycophenolate mofetil (500mg)\nMycoplasm M 500 is a medication containing Mycophenolate Mofetil in a 500mg dose. Mycophenolate Mofetil is an immunosuppressive drug used to prevent rejection in organ transplantation, particularly kidney, heart, and liver transplants. It works by inhibiting the proliferation of T and B lymphocytes, which are involved in the immune response that leads to rejection.\n\nThis medication is typically prescribed in combination with other immunosuppressants as part of a comprehensive transplant treatment regimen. It is important to take Mycoplasm M 500 exactly as prescribed by your healthcare provider to ensure optimal therapeutic outcomes and to minimize the risk of rejection or other complications.\n\nCommon side effects of Mycophenolate Mofetil may include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain. It can also increase the risk of infections due to its immunosuppressive effects. Patients should be monitored regularly by their healthcare provider while taking this medication to assess for any potential adverse effects and to adjust the dosage as needed.\n\nMycoplasm M 500 should not be used in pregnant women or those planning to become pregnant without consulting a healthcare professional, as it can cause harm to the developing fetus. Additionally, it may interact with other medications, so it is important to inform your doctor about all the medications you are currently taking before starting Mycoplasm M 500 therapy.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \n\n\n\n\nMycophenolate mofetil 500 mg stands as a cornerstone in modern immunosuppressive therapy, primarily designed to prevent organ transplant rejection in kidney, heart, and liver recipients. As a prodrug, it rapidly converts to its active form, mycophenolic acid (MPA), which selectively targets the proliferation of T and B lymphocytes—key players in immune responses that can attack transplanted organs. This medication, available in convenient 500 mg tablets, offers reliable protection against acute rejection episodes, making it an essential component in post-transplant regimens worldwide.​\n\nProduct Uses\nMycophenolate mofetil 500 mg finds its primary application in solid organ transplantation, where it helps maintain long-term graft survival. For kidney transplant patients, it is typically administered alongside corticosteroids and calcineurin inhibitors like cyclosporine or tacrolimus to suppress the immune system's overreaction to the new organ. In heart and liver transplants, it plays a similar role, reducing the incidence of rejection by inhibiting antibody production and cell-mediated immunity.​\n\nBeyond transplants, healthcare providers increasingly use mycophenolate mofetil 500 mg for various autoimmune conditions. It effectively manages lupus nephritis by curbing inflammation in the kidneys, showing superior efficacy over traditional therapies in preserving renal function. Rheumatoid arthritis patients benefit from its ability to dampen joint inflammation, while those with dermatomyositis or scleroderma experience reduced skin and muscle involvement. Off-label, it treats inflammatory bowel diseases like Crohn's disease and even certain skin disorders such as pemphigus vulgaris, where immune-mediated blistering threatens quality of life.​\n\nKey Benefits\nThe therapeutic advantages of mycophenolate mofetil 500 mg extend far beyond basic immunosuppression, offering patients enhanced outcomes and improved daily living.\n\nSuperior Graft Protection: Clinical data highlight reduced acute rejection rates by up to 50% when combined with standard regimens, leading to better long-term organ function and survival.​\n\nSelective Lymphocyte Targeting: By depleting guanosine nucleotides in T and B cells via inosine monophosphate dehydrogenase (IMPDH) inhibition, it spares other cell types, minimizing broad toxicity seen with older immunosuppressants.​\n\nAnti-Inflammatory Effects: MPA inhibits adhesion molecule glycosylation, preventing lymphocyte recruitment to inflamed sites, which alleviates symptoms in autoimmune flares.​\n\nOral Convenience: The 500 mg formulation allows flexible dosing—typically 1 gram twice daily—without the need for injections, improving patient adherence.​\n\nVersatility Across Conditions: Proven efficacy in lupus, vasculitis, and myositis expands its utility, often allowing steroid dose reduction and fewer relapses.​\n\nCardiovascular and Anticancer Potential: Emerging evidence suggests it delays graft atherosclerosis by reducing lipid oxidation and may hinder tumor progression in certain malignancies due to its impact on nucleotide synthesis.​\n\nThese benefits translate to fewer hospital readmissions, better quality of life, and cost savings in long-term care for transplant and autoimmune patients.​\n\nSide Effects\nWhile mycophenolate mofetil 500 mg provides robust immunosuppression, it carries risks typical of this drug class, necessitating vigilant monitoring.\n\nCommon side effects affect the gastrointestinal tract most prominently, with nausea, vomiting, diarrhea, and abdominal pain occurring in over 30% of users. These often improve with dose adjustments or enteric-coated alternatives, but hydration and antiemetics help manage them effectively.​\n\nHematologic issues like leukopenia, anemia, and thrombocytopenia arise due to bone marrow suppression, requiring regular complete blood counts—weekly initially, then monthly. Infections pose a significant threat, as suppressed immunity increases susceptibility to viral (e.g., CMV), bacterial, and fungal pathogens; prophylactic antivirals are standard.​\n\nLess frequent but notable effects include hypertension, tremor, insomnia, and elevated liver enzymes. Women face heightened risks of congenital malformations if used during pregnancy, mandating effective contraception and pregnancy testing. Rare severe reactions encompass progressive multifocal leukoencephalopathy (PML) from JC virus reactivation and hypersensitivity syndromes.​\n\nDosage and Administration Notes\nStandard dosing for renal transplants involves 1 gram (two 500 mg tablets) twice daily, starting within 72 hours post-surgery, with adjustments for renal impairment. Hepatic transplant patients may require higher initial doses due to metabolism differences. Always take on an empty stomach with water to optimize absorption, avoiding antacids that bind MPA.​\n\nPrecautions and Interactions\nPatients must avoid live vaccines, report fevers promptly, and undergo TB screening pre-treatment. Drug interactions with azathioprine, cholestyramine, or rifampin can alter levels, so pharmacists review regimens closely. Regular monitoring of MPA blood levels ensures therapeutic efficacy without toxicity.​\n\nConclusion\nMycophenolate mofetil 500 mg emerges as a transformative immunosuppressive agent, safeguarding transplanted organs and taming autoimmune storms with its precise mechanism of lymphocyte suppression and anti-inflammatory prowess. By delivering key benefits like reduced rejection, versatile applications, and manageable administration, it empowers patients to reclaim normalcy post-transplant or amid chronic illness. Despite potential side effects, proactive monitoring and personalized dosing mitigate risks, underscoring its value in contemporary medicine. For those navigating transplant recovery or autoimmune challenges, this medication offers hope and stability, backed by decades of clinical validation.\n\n", "price": 775.0, "discountamount": 256.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "part", "Call", "harm", "risk", "Email", "heart", "ORDER", "nausea", "kidney", "dosage", "doctor", "vomiting", "WhatsApp", "Patients", "diarrhea", "rejection", "infections", "500mg dose", "combination", "information", "sterisonline", "proliferation", "B lymphocytes", "abdominal pain", "pregnant women", "immune response", "developing fetus", "other medications", "liver transplants", "other complications", "healthcare provider", "Common side effects", "organ transplantation", "Mycophenolate mofetil", "immunosuppressive drug", "Mycoplasm M 500 therapy", "healthcare professional", "other immunosuppressants", "immunosuppressive effects", "potential adverse effects", "optimal therapeutic outcomes", "gastrointestinal disturbances", "comprehensive transplant treatment regimen" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1472, "imageuri": "https://productimages.withfloats.com/actual/6661a57fdd39d2ccddbc3bb9.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6661a57fdd39d2ccddbc3bb9.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:03:09.216Z", "updatedon": "2025-12-04T07:15:30.023Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/mycophenolate-mofetil-500mg/1472", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MYCOPLASM M 500", "category": "NEPHROLOGYRANGE", "tags": [ "MYCOPLASM M 500", "Mycophenolate mofetil (500mg)", "Mycophenolate mofetil 500 mg tablet", "Mycophenolate mofetil 500 mg price", "Mycophenolate mofetil 500 mg dosage", "Mycophenolate mofetil uses", "Mycophenolate mofetil side effects", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6661614c870e7b20c49e4e49", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PIOSTERIS 7.5 ", "description": "PIOSTERIS 7.5 \nPioglitazone (7.5mg)\nIntroduction to PIOSTERIS 7.5\nPIOSTERIS 7.5 contains Pioglitazone 7.5mg, a medication used primarily for the management of type 2 diabetes mellitus. Pioglitazone belongs to a class of drugs known as thiazolidinediones (TZDs), which help improve blood sugar control by increasing the body's sensitivity to insulin. This medication is typically used in combination with diet and exercise to enhance glycemic control in adults with type 2 diabetes.\n\nWhat is Pioglitazone?\nOverview of Pioglitazone\nPioglitazone is an oral diabetes medication that works by making cells more sensitive to insulin, thereby allowing the body to use insulin more effectively. This helps lower blood sugar levels in patients with type 2 diabetes. Pioglitazone can be used alone or in combination with other antidiabetic medications.\n\nMechanism of Action\nInsulin Sensitization: Pioglitazone activates peroxisome proliferator-activated receptor gamma (PPARγ) receptors, which are involved in the regulation of genes responsible for glucose and lipid metabolism. This activation increases the sensitivity of body tissues to insulin.\nGlucose Uptake: By improving insulin sensitivity, Pioglitazone enhances glucose uptake in muscle and adipose tissue and reduces hepatic glucose production, leading to lower blood sugar levels.\nBenefits of PIOSTERIS 7.5\nEffective Blood Sugar Management\nImproved Insulin Sensitivity: PIOSTERIS 7.5 helps improve the body's response to insulin, leading to better control of blood sugar levels.\nComprehensive Glycemic Control: By targeting insulin resistance, Pioglitazone provides a unique mechanism of action that complements other diabetes medications, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: PIOSTERIS 7.5 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, PIOSTERIS 7.5 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nLipid Profile Improvement: Pioglitazone has been shown to improve lipid profiles by lowering triglycerides and increasing HDL cholesterol levels, which can provide additional cardiovascular benefits.\nHow to Use PIOSTERIS 7.5\nDosage and Administration\nRecommended Dosage: The typical dosage of PIOSTERIS 7.5 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food. Swallow the tablet whole with a full glass of water. Consistency is key, so take the medication at the same time each day.\nGuidelines for Optimal Use\nConsistent Use: For best results, take PIOSTERIS 7.5 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/piosteris-7-5-133430", "price": 59.0, "discountamount": 17.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "food", "TZDs", "diet", "lower", "cells", "class", "water", "drugs", "EMAIL", "Order", "genes", "adults", "muscle", "Action", "Support", "readings", "Overview", "patients", "same time", "PIOSTERIS", "one tablet", "full glass", "regulation", "activation", "neuropathy", "Guidelines", "retinopathy", "combination", "Consistency", "Adjustments", "information", "Optimal Use", "best results", "Reduced Risk", "sterispharma", "body tissues", "Pioglitazone", "Introduction", "sterisonline", "triglycerides", "CALL/WHATSAPP", "typical dosage", "Administration", "treatment plan", "Consistent Use", "lipid profiles", "adipose tissue", "Glucose Uptake", "Exercise Adjunct", "lipid metabolism", "unique mechanism", "PPARγ) receptors", "excellent adjunct", "insulin resistance", "thiazolidinediones", "Recommended Dosage", "insulin sensitivity", "Diabetes Management", "blood sugar control", "healthcare provider", "individual response", "Insulin Sensitization", "cardiovascular disease", "HDL cholesterol levels", "long-term complications", "lifestyle modifications", "oral diabetes medication", "type 2 diabetes mellitus", "Lipid Profile Improvement", "stable blood sugar levels", "other diabetes medications", "Additional Health Benefits", "hepatic glucose production", "Comprehensive Glycemic Control", "other antidiabetic medications", "Effective Blood Sugar Management", "additional cardiovascular benefits", "comprehensive blood sugar management", "peroxisome proliferator-activated receptor gamma" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1410, "imageuri": "https://productimages.withfloats.com/actual/6661614f7b1fc3f9dd4c82f7.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661614f7b1fc3f9dd4c82f7.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T07:12:12.153Z", "updatedon": "2024-06-29T10:23:25.301Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/piosteris-7-5-/1410", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PIOSTERIS 7.5 ", "category": "DIABETIC RANGE", "tags": [ "PIOSTERIS 7.5", "Pioglitazone (7.5mg)", "pioz 7.5 price", "pioz 7.5 side effects", "tab pioz 7.5 uses", "pioz 7.5 tablet 10" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }